Skip to main content

Articles

Page 6 of 8

  1. EQ-5D-3L valuation studies continue to employ the MVH protocol or variants of MVH. One issue that has received attention is the selection of the states for direct valuation by respondents. Changes in the valua...

    Authors: Henry Bailey, Paul Kind and Althea La Foucade

    Citation: Health Economics Review 2014 4:29

    Content type: Research

    Published on:

  2. Diabetes Mellitus Type II (T2DM) is a major and growing medical, social and economic burden in the East-Asian country of Cambodia. However, no economic modelling has been done to predict the number of cases an...

    Authors: Steffen Flessa and Anika Zembok

    Citation: Health Economics Review 2014 4:24

    Content type: Research

    Published on:

  3. The aim of this study is to estimate the cost of care and treatment for extremely low birth weight (ELBW) neonates admitted to a teaching and referral hospital. This cost estimation project can help health pol...

    Authors: Hosein Dalili, Mohaddese Fallahi, Saeid Moradi, Fatemeh Nayeri, Mamak Shariat and Arash Rashidian

    Citation: Health Economics Review 2014 4:21

    Content type: Research

    Published on:

  4. The introduction of the European Working Time Directive (EWTD) has greatly reduced training hours of surgical residents, which translates into 30% less surgical and clinical experience. Such a dramatic drop in...

    Authors: Simon Schimmack, Ulf Hinz, Andreas Wagner, Thomas Schmidt, Hendrik Strothmann, Markus W Büchler and Hubertus Schmitz-Winnenthal

    Citation: Health Economics Review 2014 4:14

    Content type: Research

    Published on:

  5. To assess the impact of reference pricing and extension of generic substitution on the daily cost of antipsychotic drugs in Finland during the first year after its launch. Furthermore, the additional impact of...

    Authors: Hanna Koskinen, Elina Ahola, Leena K Saastamoinen, Hennamari Mikkola and Jaana E Martikainen

    Citation: Health Economics Review 2014 4:9

    Content type: Research

    Published on:

  6. In Switzerland, age is the predominant driver of solidarity transfers in risk adjustment (RA). Concerns have been voiced regarding growing imbalances in cost sharing between young and old insured due to demogr...

    Authors: Viktor von Wyl and Konstantin Beck

    Citation: Health Economics Review 2014 4:7

    Content type: Research

    Published on:

  7. While induced abortion is considered to be illegal and socially unacceptable in Nigeria, it is still practiced by many women in the country. Poor family planning and unsafe abortion practices have daunting eff...

    Authors: Bosede O Awoyemi and Jacob Novignon

    Citation: Health Economics Review 2014 4:3

    Content type: Research

    Published on:

  8. To identify associations between market factors, especially relative reimbursement rates, and the probability of surgery and cost per episode for three medical conditions (cataract, benign prostatic neoplasm, ...

    Authors: Jack Hadley, James D Reschovsky, James A O’Malley and Bruce E Landon

    Citation: Health Economics Review 2014 4:8

    Content type: Research

    Published on:

  9. In the majority of children and adolescents with epilepsy, optimal drug therapy adequately controls their condition. However, among the remaining patients who are still uncontrolled despite mono-, bi- or tri-t...

    Authors: Dawn C Lee, Daniel Gladwell, Anthony J Hatswell, Joshua Porter, Nic Brereton, Elaine Tate and Alison L Saunders

    Citation: Health Economics Review 2014 4:6

    Content type: Research

    Published on:

  10. The prospective reimbursement of hospitals through the grouping of patients into a finite number of categories (Diagnosis Related Groups, DRGs), is common to many European countries. However, the specific cate...

    Authors: James Gaughan and Conrad Kobel

    Citation: Health Economics Review 2014 4:4

    Content type: Research

    Published on:

  11. The German AMNOG healthcare reform includes a mandatory early-benefit-assessment (EBA) at launch. As per German social code, EBA is based on registration trials and includes evaluation of the patient-relevant ...

    Authors: Inna Dabisch, Jürgen Dethling, Charalabos-Markos Dintsios, Melanie Drechsler, Daniel Kalanovic, Peter Kaskel, Frank Langer, Jörg Ruof, Thorsten Ruppert and Daniel Wirth

    Citation: Health Economics Review 2014 4:2

    Content type: Review

    Published on:

  12. Care of stroke patients costs considerably more in specialized stroke units (SU) compared to care in general medical wards (GMW) but the technology may be cost effective if it leads to significantly improved o...

    Authors: Farasat AS Bokhari, Ian Wellwood, Anthony G Rudd, Peter Langhorne, Martin S Dennis and Charles DA Wolfe

    Citation: Health Economics Review 2014 4:1

    Content type: Research

    Published on:

  13. In April 2008, specialization in gynecology and obstetrics departments was introduced in the Sennan area of Osaka prefecture in Japan that aimed at solving the problems of regional provisions of obstetrics ser...

    Authors: Yoshimi Adachi, Hiroyasu Iso, Junyi Shen, Kanami Ban, On Fukui, Hiroyuki Hashimoto, Takako Nakashima, Kenichiro Morishige and Tatuyoshi Saijo

    Citation: Health Economics Review 2013 3:31

    Content type: Research

    Published on:

  14. Patient-centered health care and shared decision making are of increasing importance in the management of AIDS/HIV patients and require an intensive consideration of patient preferences. The present study asse...

    Authors: Axel C Mühlbacher, Matthias Stoll, Jörg Mahlich and Matthias Nübling

    Citation: Health Economics Review 2013 3:30

    Content type: Research

    Published on:

  15. Recently the sequencing of the human genome has become a major biological and clinical research field. However, the public health impact of this new technology with focus on the financial effect is not yet to ...

    Authors: Martin Frank, Anne Prenzler, Roland Eils and J-Matthias Graf von der Schulenburg

    Citation: Health Economics Review 2013 3:29

    Content type: Review

    Published on:

  16. The objective of the study was to analyse whether azacitidine is a cost-effective option for the treatment of myelodysplastic syndrome in the Spanish setting compared with conventional care regimens, including...

    Authors: Carlos Crespo, Estela Moreno, Jordi Sierra, Suzan Serip and Marta Rubio

    Citation: Health Economics Review 2013 3:28

    Content type: Research

    Published on:

  17. Rotavirus gastroenteritis (RVGE) is a frequent disease in young children. The recommended German paediatric immunisation schedule does not currently include rotavirus vaccination. A lack of economic data on th...

    Authors: Stefanie Knoll, Christoph Mair, Ursula Benter, Katja Vouk and Baudouin Standaert

    Citation: Health Economics Review 2013 3:27

    Content type: Research

    Published on:

  18. Respiratory syncytial virus (RSV) is a common cause of respiratory infection that is highly prevalent in infants. Severe cases of RSV infection require hospitalisation; this is most likely to occur in infant p...

    Authors: Anthony Bentley, Ivana Filipovic, Katherine Gooch and Katharina Büsch

    Citation: Health Economics Review 2013 3:18

    Content type: Research

    Published on:

  19. Fingolimod is an innovative drug with a significant budget impact in the treatment of MS in Spain. The aim of this study was to calculate the direct cost comparison of glatiramer acetate and fingolimod for the...

    Authors: Rainel Sanchez-de la Rosa, Eliazar Sabater and Miguel A Casado

    Citation: Health Economics Review 2013 3:13

    Content type: Research

    Published on:

  20. The reliance on out-of-pocket payments for health services leads to a catastrophic burden for many households in Bangladesh. The World Health Organization suggests that risk-pooling mechanisms should be used f...

    Authors: Jahangir AM Khan and Sayem Ahmed

    Citation: Health Economics Review 2013 3:12

    Content type: Research

    Published on:

  21. The increasing prevalence of diabetes and its inadequate management results in a heavy burden of the disease for the patients, the health and the productive system and the overall community. Consequently, it i...

    Authors: Jorge F Elgart, Joaquin E Caporale, Lorena Gonzalez, Eleonora Aiello, Maximiliano Waschbusch and Juan J Gagliardino

    Citation: Health Economics Review 2013 3:11

    Content type: Research

    Published on:

Annual Journal Metrics